JDPRX
Price
$15.29
Change
-$0.20 (-1.29%)
Updated
Jun 13 closing price
Net Assets
1.94B
MVCAX
Price
$30.04
Change
-$0.44 (-1.44%)
Updated
Jun 13 closing price
Net Assets
16.57B
Interact to see
Advertisement

JDPRX vs MVCAX

Header iconJDPRX vs MVCAX Comparison
Open Charts JDPRX vs MVCAXBanner chart's image
Janus Henderson Mid Cap Value R
Price$15.29
Change-$0.20 (-1.29%)
VolumeN/A
Net Assets1.94B
MFS Mid Cap Value A
Price$30.04
Change-$0.44 (-1.44%)
VolumeN/A
Net Assets16.57B
JDPRX vs MVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDPRX vs. MVCAX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDPRX is a Buy and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.6B vs. JDPRX (1.94B). MVCAX pays higher dividends than JDPRX: MVCAX (0.89) vs JDPRX (0.14). JDPRX was incepted earlier than MVCAX: JDPRX (16 years) vs MVCAX (24 years). JDPRX (1.39) is less costly to investors than MVCAX (1.00). JDPRX is a more actively managed with annual turnover of: 37.00 vs. MVCAX (27.00). MVCAX has a lower initial minimum investment than JDPRX: MVCAX (1000) vs JDPRX (2500). JDPRX annual gain was more profitable for investors over the last year : -3.41 vs. MVCAX (-4.53). MVCAX return over 5 years is better than : 51.98 vs. JDPRX (17.91).
JDPRXMVCAXJDPRX / MVCAX
Total Expense Ratio1.390.99140%
Annual Report Gross Expense Ratio1.391.00139%
Fund Existence16 years24 years-
Gain YTD-1.355-2.08665%
Front LoadN/A6%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets1.94B16.6B12%
Annual Yield % from dividends0.140.8916%
Returns for 1 year-3.41-4.5375%
Returns for 3 years5.4413.0042%
Returns for 5 years17.9151.9834%
Returns for 10 years-21.2853.51-40%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGEN1.52N/A
N/A
Precigen
VIRT41.12-0.01
-0.02%
Virtu Financial
ACN311.71-6.42
-2.02%
Accenture PLC
FUTU111.50-2.62
-2.30%
Futu Holdings Limited
DERM6.78-0.19
-2.73%
Journey Medical Corp